ArticleCancer science2009

Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts.

Michio Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.